Company Search:
Advanced Search
Sponsored Links
Orion Oyj Company Snapshot
Orion Oyj operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Orion Oyj with three other pharmaceutical manufacturers in Europe: Alkermes Plc of IRELAND (2019 sales of 1.05 billion Euros [US$1.27 billion] of which 100% was Medicines), Almirall SA of SPAIN (855.34 million Euros [US$1.04 billion] of which 63% was Own Network (Spain)), and Virbac which is based in FRANCE (938.34 million Euros [US$1.14 billion] of which 59% was Companion Animals).

Sales Analysis. During the year ended December of 2019, sales at Orion Oyj were 1.05 billion Euro (US$1.27 billion). This is an increase of 7.5% versus 2018, when the company's sales were 977.50 million Euro. Despite this increase, sales are still below the level achieved in 2017, when Orion Oyj reported sales of 1.08 billion Euro. The sales level in 2019 was fairly close to the level five years ago: in 2014, Orion Oyj had sales of 1.02 billion Euro.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Orion Oyj
  Stock Performance Chart for Orion Oyj
  Stock Data: Recent Stock Performance:
  Current Price (1/15/2021): 39.15
(Figures in Euros )
1 Week 4.3%   13 Weeks 3.3%  
4 Weeks 1.6%   52 Weeks -11.0%  
Orion Oyj Key Data:
  Ticker: ORNBV Country: Finland
  Exchanges: HEL Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2019 Sales 1,051,000,000
(Year Ending Jan 2020).
Employees: 3,265
  Currency: Euros Market Cap: 5,499,134,123
  Fiscal Yr Ends: December Shares Outstanding: 140,463,196
  Share Type: B Osake Closely Held Shares: 17,264,729
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.